Yanwen Huang

Drugging the Undruggable: Benchmarking and Modeling Fragment-Based Screening

CIDD: Collaborative Intelligence for Structure-Based Drug Design Empowered by LLMs

Redefining the task of Bioactivity Prediction

Reframing Structure-Based Drug Design Model Evaluation via Metrics Correlated to Practical Needs

MoleculeCLA: Rethinking Molecular Benchmark via Computational Ligand-Target Binding Analysis